Profiel
Nancy C.
Broadbent formerly worked at Human Genome Sciences, Inc., as Chief Financial Officer & Senior Vice President in 1996, CollaGenex Pharmaceuticals, Inc., as Chief Financial Officer from 1996 to 2008, Orthovita, Inc., as Chief Financial Officer & Senior Vice President in 2009, and Cangene Corp., as Chief Financial Officer & Vice President in 1994.
Ms. Broadbent received her undergraduate degree from the University of Virginia and Masters Business Admin degree from The Trustees of Columbia University in The City of New York.
Eerdere bekende functies van Nancy C. Broadbent
| Bedrijven | Functie | Einde |
|---|---|---|
Orthovita, Inc.
 Orthovita, Inc. Medical SpecialtiesHealth Technology Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA. | Financieel Directeur/CFO | 27-06-2011 |
CollaGenex Pharmaceuticals, Inc.
 CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Financieel Directeur/CFO | 01-04-2008 |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Financieel Directeur/CFO | 01-03-1996 |
| CANGENE CORPORATION | Financieel Directeur/CFO | 01-10-1994 |
Opleiding van Nancy C. Broadbent
| University of Virginia | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Health Technology |
Orthovita, Inc.
Orthovita, Inc. Medical SpecialtiesHealth Technology Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA. | Health Technology |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Cangene Corp.
 Cangene Corp. Pharmaceuticals: MajorHealth Technology Cangene Corp. developed, manufactured and sold biopharmaceutical drugs. The company was founded on February 22, 1984 and was headquartered in Winnipeg, Canada. | Health Technology |
